Literature DB >> 22467656

Aberrant macrophages mediate defective kidney repair that triggers nephritis in lupus-susceptible mice.

Yasunori Iwata1, Elisabeth A Boström, Julia Menke, Whitney A Rabacal, Laurence Morel, Takashi Wada, Vicki R Kelley.   

Abstract

CSF-1, required for macrophage (Mø) survival, proliferation, and activation, is upregulated in the tubular epithelial cells (TECs) during kidney inflammation. CSF-1 mediates Mø-dependent destruction in lupus-susceptible mice with nephritis and, paradoxically, Mø-dependent renal repair in lupus-resistant mice after transient ischemia/reperfusion injury (I/R). We now report that I/R leads to defective renal repair, nonresolving inflammation, and, in turn, early-onset lupus nephritis in preclinical MRL/MpJ-Faslpr/Fas(lpr) mice (MRL-Fas(lpr) mice). Moreover, defective renal repair is not unique to MRL-Fas(lpr) mice, as flawed healing is a feature of other lupus-susceptible mice (Sle 123) and MRL mice without the Fas(lpr) mutation. Increasing CSF-1 hastens renal healing after I/R in lupus-resistant mice but hinders healing, exacerbates nonresolving inflammation, and triggers more severe early-onset lupus nephritis in MRL-Fas(lpr) mice. Probing further, the time-related balance of M1 "destroyer" Mø shifts toward the M2 "healer" phenotype in lupus-resistant mice after I/R, but M1 Mø continue to dominate in MRL-Fas(lpr) mice. Moreover, hypoxic TECs release mediators, including CSF-1, that are responsible for stimulating the expansion of M1 Mø inherently poised to destroy the kidney in MRL-Fas(lpr) mice. In conclusion, I/R induces CSF-1 in injured TECs that expands aberrant Mø (M1 phenotype), mediating defective renal repair and nonresolving inflammation, and thereby hastens the onset of lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22467656      PMCID: PMC3340928          DOI: 10.4049/jimmunol.1102154

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases.

Authors:  V A Fadok; D L Bratton; L Guthrie; P M Henson
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

Review 2.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

Authors:  Alberto Mantovani; Silvano Sozzani; Massimo Locati; Paola Allavena; Antonio Sica
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

3.  Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells.

Authors:  Paul K Potter; Josefina Cortes-Hernandez; Pierre Quartier; Marina Botto; Mark J Walport
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

4.  Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation.

Authors:  Deborah M Lenda; Eriya Kikawada; E Richard Stanley; Vicki R Kelley
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

Review 5.  Etiopathogenesis of murine SLE.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

6.  Increase in macrophage Ia expression in autoimmune mice: role of the Ipr gene.

Authors:  V E Kelley; J B Roths
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

7.  IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.

Authors:  Eriya Kikawada; Deborah M Lenda; Vicki R Kelley
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

8.  Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.

Authors:  Deborah M Lenda; E Richard Stanley; Vicki R Kelley
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

9.  The MRL mouse repairs both cryogenic and ischemic myocardial infarcts with scar.

Authors:  Philippe Grisel; Andrea Meinhardt; Hans-Anton Lehr; Lukas Kappenberger; Yann Barrandon; Giuseppe Vassalli
Journal:  Cardiovasc Pathol       Date:  2007-04-02       Impact factor: 2.185

10.  Scar formation after ischemic myocardial injury in MRL mice.

Authors:  Yong-Seog Oh; Louise E J Thomson; Michael C Fishbein; Daniel S Berman; Behrooz Sharifi; Peng-Sheng Chen
Journal:  Cardiovasc Pathol       Date:  2004 Jul-Aug       Impact factor: 2.185

View more
  48 in total

1.  IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-Faslpr Mice.

Authors:  Yukihiro Wada; Hilda M Gonzalez-Sanchez; Julia Weinmann-Menke; Yasunori Iwata; Amrendra K Ajay; Myriam Meineck; Vicki R Kelley
Journal:  J Am Soc Nephrol       Date:  2019-01-08       Impact factor: 10.121

2.  Dependence of Glomerulonephritis Induction on Novel Intraglomerular Alternatively Activated Bone Marrow-Derived Macrophages and Mac-1 and PD-L1 in Lupus-Prone NZM2328 Mice.

Authors:  Sun-Sang J Sung; Yan Ge; Chao Dai; Hongyang Wang; Shu Man Fu; Rahul Sharma; Young S Hahn; Jing Yu; Thu H Le; Mark D Okusa; Warren K Bolton; Jessica R Lawler
Journal:  J Immunol       Date:  2017-02-20       Impact factor: 5.422

Review 3.  Autoimmunity and organ damage in systemic lupus erythematosus.

Authors:  George C Tsokos
Journal:  Nat Immunol       Date:  2020-05-04       Impact factor: 25.606

4.  Leukotriene B4 promotes neovascularization and macrophage recruitment in murine wet-type AMD models.

Authors:  Fumiyuki Sasaki; Tomoaki Koga; Mai Ohba; Kazuko Saeki; Toshiaki Okuno; Keijiro Ishikawa; Takahito Nakama; Shintaro Nakao; Shigeo Yoshida; Tatsuro Ishibashi; Hamid Ahmadieh; Mozhgan Rezaei Kanavi; Ali Hafezi-Moghadam; Josef M Penninger; Koh-Hei Sonoda; Takehiko Yokomizo
Journal:  JCI Insight       Date:  2018-09-20

Review 5.  Links between coagulation, inflammation, regeneration, and fibrosis in kidney pathology.

Authors:  Beatriz Suárez-Álvarez; Helen Liapis; Hans-Joachim Anders
Journal:  Lab Invest       Date:  2016-01-11       Impact factor: 5.662

6.  An agonist antibody that blocks autoimmunity by inducing anti-inflammatory macrophages.

Authors:  Kyung Ho Han; Rosana Gonzalez-Quintial; Yingjie Peng; Roberto Baccala; Argyrios N Theofilopoulos; Richard A Lerner
Journal:  FASEB J       Date:  2015-10-19       Impact factor: 5.191

Review 7.  Metabolic Factors that Contribute to Lupus Pathogenesis.

Authors:  Wei Li; Ramya Sivakumar; Anton A Titov; Seung-Chul Choi; Laurence Morel
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

Review 8.  Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years.

Authors:  Zachary Oaks; Thomas Winans; Nick Huang; Katalin Banki; Andras Perl
Journal:  Curr Rheumatol Rep       Date:  2016-12       Impact factor: 4.592

9.  Specific macrophage subtypes influence the progression of rhabdomyolysis-induced kidney injury.

Authors:  Julie Belliere; Audrey Casemayou; Laure Ducasse; Alexia Zakaroff-Girard; Frédéric Martins; Jason S Iacovoni; Céline Guilbeau-Frugier; Bénédicte Buffin-Meyer; Bernard Pipy; Dominique Chauveau; Joost P Schanstra; Jean-Loup Bascands
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

Review 10.  Renal Macrophages and Dendritic Cells in SLE Nephritis.

Authors:  Naomi I Maria; Anne Davidson
Journal:  Curr Rheumatol Rep       Date:  2017-11-09       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.